SRR8943008
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- BILE_ACID_METABOLISM+0.150
- NOTCH_SIGNALING+0.040
- PEROXISOME+0.040
- TGF_BETA_SIGNALING+0.010
- WNT_BETA_CATENIN_SIGNALING+0.010
- MYC_TARGETS_V2-0.020
- PROTEIN_SECRETION-0.050
- KRAS_SIGNALING_DN-0.090
- PANCREAS_BETA_CELLS-0.090
- XENOBIOTIC_METABOLISM-0.090
Top 10 suppressed
- E2F_TARGETS-0.570
- G2M_CHECKPOINT-0.550
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.510
- ANGIOGENESIS-0.490
- CHOLESTEROL_HOMEOSTASIS-0.450
- IL6_JAK_STAT3_SIGNALING-0.440
- INTERFERON_ALPHA_RESPONSE-0.430
- INTERFERON_GAMMA_RESPONSE-0.410
- INFLAMMATORY_RESPONSE-0.360
- MTORC1_SIGNALING-0.360
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | C3N-03420 | — | cohortA1 | 0.929 |
| 2 | R247 | — | — | 0.925 |
| 3 | TCGA-CF-A5U8-01A-11R-A28M-07 | — | — | 0.911 |
| 4 | TCGA-LT-A8JT-01A-11R-A36F-07 | — | — | 0.909 |
| 5 | TCGA-CF-A27C-01A-11R-A16R-07 | — | — | 0.903 |
| 6 | EPT0291 | EPN | EPN Tumor | 0.896 |
| 7 | SRR8613727 | — | D | 0.894 |
| 8 | SRR8942980 | — | — | 0.893 |
| 9 | TCGA-FD-A43X-01A-11R-A23W-07 | — | — | 0.892 |
| 10 | MBCProject_0004_T1_RNA | — | C | 0.890 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 5 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| BILE_ACID_METABOLISM | 0.150 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.040 | Inavolisib | — uncovered |
| PEROXISOME | 0.040 | Idelalisib | — uncovered |
| TGF_BETA_SIGNALING | 0.010 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.010 | Inavolisib | — uncovered |